Nih Nci Dctd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NIH NCI DCTD, and what generic and branded alternatives to NIH NCI DCTD drugs are available?
NIH NCI DCTD has one approved drug.
Summary for Nih Nci Dctd
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Nih Nci Dctd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nih Nci Dctd | SODIUM FLUORIDE F 18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 022494-001 | Jan 26, 2011 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
